id,disease_progression_status,survival_status,clinical_response_rate_target_lasion,clinical_response_rate_non_target_lasion,clinical_response_rate_new_lasion,clinical_response_rate_result,radiological_response_rate_target_lasion,radiological_response_rate_non_target_lasion,radiological_response_rate_new_lasion,radiological_response_rate_result,pathological_response_rate_target_lasion,pathological_response_rate_non_target_lasion,pathological_response_rate_new_lasion,pathological_response_rate_result,time,registration_number,laterality,current_chemo_protocol,chemo_starting_date,chemo_cycle_no,chemo_detail,disease_progression_status_date,pfs,survival_status_date,overall_survival,clinical_response_rate_date,radiological_response_rate_date,pathological_response_rate_date,cancer_type,patient_id_id,patient_id_socio_economic_status_name,patient_id_unique_id,patient_id_name,patient_id_phone,patient_id_date_of_birth,patient_id_gender,patient_id_blood_group,patient_id_area,patient_id_police_station,patient_id_district,doctor_id_name,center_id_name,grade_name,line_of_treatment_name,diagnosis_disease_group_name,diagnosis_subgroup_diagnosis_disease_group_name,diagnosis_subgroup_name,diagnosis_primary_site_name,diagnosis_laterility_name,patient_id_socio_economic_status,grade,disease_progression_status_name,survival_status_name,clinical_response_rate_target_lasion_name,clinical_response_rate_non_target_lasion_name,clinical_response_rate_new_lasion_name,clinical_response_rate_result_name,radiological_response_rate_target_lasion_name,radiological_response_rate_non_target_lasion_name,radiological_response_rate_new_lasion_name,radiological_response_rate_result_name,diagnosis_laterility,line_of_treatment,diagnosis_subgroup,pathological_response_rate_target_lasion_name,pathological_response_rate_non_target_lasion_name,pathological_response_rate_new_lasion_name,pathological_response_rate_result_name,diagnosis_disease_group,diagnosis_primary_site,name,value,unit,date,patient_observation_id
353,,,,,,,,,,,,,,,2024-06-26T16:36:43+06:00,BSH - H11910061606,Left,Palbociclib+Letrozole,2020-11-01,,"8 cycles of CT with AC (4 cycles) x Pacli ( 4 cycles) upto 11.05.19 > GemcitabineVinorelbine, Cycle 6 till 25/03/20 > Inj. Zoledronic acid,  22 cycle still date. 
Tab Temoxifen > Tab Xeloda, starting April/20, 08 cycles till date> On Letrozole- Palbociclib (from Nov/20)",2024-03-10,,2024-03-12,,2020-04-23,,2018-11-08,Breast,338,Middle class,BSBSC-240000338,MRS. SUFIA  KHATUN,1720246390,1965-10-25,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,2.0,Switch Maintenance,C50- Malignant neoplasm of breast,C50- Malignant neoplasm of breast,"C50.9- Breast, unspecified",Breast,Left,,,Stable,Alive,CR,,,,,,,,,,,PR,,,,,,,,,,
